Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism
- 1 August 1991
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 69 (12) , 522-526
- https://doi.org/10.1007/bf01649289
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolismThe Lancet, 1991
- PLASMA D-DIMER AND PULMONARY EMBOLISMThe Lancet, 1989
- Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolismAmerican Heart Journal, 1988
- Monoclonal antibodies to crosslinked fibrin degradation products (XL‐FDP) II. EVALUATION IN A VARIETY OF CLINICAL CONDITIONSBritish Journal of Haematology, 1988
- Fibrin and Fibrinogen-Related Antigens in Patients with Stable and Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1987
- Ein Test zum Nachweis von Fibrin im PlasmaGeburtshilfe und Frauenheilkunde, 1986
- Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systemsBritish Journal of Haematology, 1985
- Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.Journal of Clinical Pathology, 1984
- Natural history of pulmonary embolismProgress in Cardiovascular Diseases, 1975
- ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISMThe Lancet, 1960